131 results on '"Kamenicky, Peter"'
Search Results
2. X-linked hypophosphataemia
3. Aberrant hormone receptors regulate a wide spectrum of endocrine tumors
4. Acromegalic Cardiomyopathy: An Entity on its own? The Effects of GH and IGF-I Excess and Treatment on Cardiovascular Risk Factors
5. Position statement on the diagnosis and management of acromegaly: The French National Diagnosis and Treatment Protocol (NDTP)
6. Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study
7. Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome
8. Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study
9. X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience
10. Cardiovascular complications of acromegaly
11. Anatomy of the medial wall of the cavernous sinus: A systematic review of the literature.
12. Management of X-linked hypophosphatemia in adults
13. Mechanism of ectopic hormone receptors in adrenal tumors and hyperplasia
14. Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
15. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
16. Impact of Cushing's syndrome on the gonadotrope axis and testicular functions in men.
17. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET/CT
18. Primary hyperparathyroidism in pregnancy
19. Values of osteoprotegerin in aortic valve tissue in patients with significant aortic stenosis depend on the existence of concomitant coronary artery disease
20. Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study.
21. Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion
22. European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy:recommendations of the ESE Educational Program of Parathyroid Disorders
23. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy : recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021)
24. Genotype-phenotype Description of Vitamin D--dependent Rickets 1A: CYP27B1 p.(Ala129Thr) Variant Induces a Milder Disease.
25. Combining metabolomics and machine learning models as a tool to distinguish non-classic 21-hydroxylase deficiency from polycystic ovary syndrome without adrenocorticotropic hormone testing.
26. OR04-4 Loss of KDM1A in Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing's Syndrome and in Acromegaly With Paradoxical GH Response to Oral Glucose
27. Practice patterns for chronic hypoparathyroidism: data from patients and physicians in France
28. Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients
29. Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment.
30. Primary hyperparathyroidism in pregnancy
31. Acromegaly
32. European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders
33. Growing heart in congenital hypopituitarism treated in adulthood
34. Impact of Successful Treatment of Acromegaly on Overnight Heart Rate Variability and Sleep Apnea
35. Ketoconazole in Cushingʼs Disease: Is It Worth a Try?
36. An Abnormal Apelin/Vasopressin Balance May Contribute to Water Retention in Patients With the Syndrome of Inappropriate Antidiuretic Hormone (SIADH) and Heart Failure
37. Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis: Five Years of Experience in a Clinical Laboratory.
38. Treatment of acromegaly has substantial effects on body composition: a long-term follow-up study.
39. Body Fluid Expansion in Acromegaly Is Related to Enhanced Epithelial Sodium Channel (ENaC) Activity
40. TAC3 and TACR3 Defects Cause Hypothalamic Congenital Hypogonadotropic Hypogonadism in Humans
41. Osmotic Stress Regulates Mineralocorticoid Receptor Expression in a Novel Aldosterone-Sensitive Cortical Collecting Duct Cell Line
42. Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension.
43. Epithelial Sodium Channel Is a Key Mediator of Growth Hormone-Induced Sodium Retention in Acromegaly
44. Benign cortisol-secreting adrenocortical adenomas produce small amounts of androgens
45. McCune-Albright Syndrome and Acromegaly: Effects of Hypothalamopituitary Radiotherapy and/or Pegvisomant in Somatostatin Analog-Resistant Patients
46. Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome
47. Abstract #512 A Phase 3 Randomized; Placebo-Controlled Study Investigating Burosumab for Adult X-Linked Hypophosphatemia (XLH)
48. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET/CT.
49. Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early‐Onset Obesity.
50. The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-Analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.